Skip to main content
Caplight Logo









Implican

Implican

Private
GroningenHealthcare & Life Scienceshttps://implican.nl/

Last Round

Seed

Jan 10, 2023

Total Funding Raised

$1.07M

Company Overview

Implican is a medical device company that develops anastomotic devices designed to reduce anastomotic leakage in colorectal surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicecolorectal surgeryanastomotic leakagesurgical implantmedtechbowel resectioncompression-based surgerywound healingsurgical staplinganastomosisminimally invasive surgerysurgical hardwarecolorectal cancer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Implican Comparables

Compare Implican with similar companies based on industry and business-model similarity.

Implican comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CarpoNovum AB
87%
Seger Surgical Solutions
81%
Johnson & Johnson
76%

Implican Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 10, 2023

Key People

Founding team and executive leadership

Rik Kielman

Chief Executive Officer

Executive Team

Implican Investors

Notable investors and investment history

Implican investors
InvestorRounds
Nextgen VenturesSeed
Noordelijke Ontwikkelings MaatschappijSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors increased 49% MoM.

  • Jan 1, 2026

    Monthly visitors increased 335% MoM.

Implican Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Implican Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Implican's valuation, stock price, and market status.

Firmographic Details

HeadquartersGroningen
Employee Range5
Year FoundedN/A
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?